Actemra (Tocilizumab)

Actemra is a biologic therapy used to treat moderate to severe rheumatoid arthritis in adults and children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Actemra may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Actemra belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling.

Indicated for the
treatment of:

  • Rheumatoid Arthritis
  • Giant Cell Arteritis
  • Cytokine Release Syndrome
  • Coronavirus (COVID-19) (Off-Label)

Infusion Duration:

Frequency of treatment:

  • 2-4 Weeks

Technology utilized for this infusion

  • Vein Viewer (Allows us to see your vein under the skin)
  • J-Tip (Eliminates the physical pain of the IV stick)

Why people choose PURE to receive their Actemra infusion:

  • Private Suites
  • Comfortable power recliners
  • Room for guests
  • Desks to work
  • High-speed wi-fi
  • 55” 4K TVs
  • Netflix, iPad, music
  • Snacks and amenities on us